Effects of Sacubitril/Valsartan on Serum Lipids in Heart Failure With Preserved Ejection Fraction.
- DOI
- 10.1161/jaha.121.022069
- Published
- 2021 Sep 7
- Container
- Journal of the American Heart Association
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1161/jaha.121.022069,
title = {Effects of Sacubitril/Valsartan on Serum Lipids in Heart Failure With Preserved Ejection Fraction.},
author = {Selvaraj S and Claggett BL and Packer M and Zannad F and Anand IS and Pieske B and Zhao Z and Shi VC and Lefkowitz MP and McMurray JJV and Solomon SD},
year = {2021},
journal = {Journal of the American Heart Association},
doi = {10.1161/jaha.121.022069},
url = {https://doi.org/10.1161/jaha.121.022069}
}RIS
TY - JOUR TI - Effects of Sacubitril/Valsartan on Serum Lipids in Heart Failure With Preserved Ejection Fraction. AU - Selvaraj S AU - Claggett BL AU - Packer M AU - Zannad F AU - Anand IS AU - Pieske B AU - Zhao Z AU - Shi VC AU - Lefkowitz MP AU - McMurray JJV AU - Solomon SD PY - 2021 JO - Journal of the American Heart Association DO - 10.1161/jaha.121.022069 UR - https://doi.org/10.1161/jaha.121.022069 ER -
APA
S, S., BL, C., M, P., F, Z., IS, A., B, P., Z, Z., VC, S., MP, L., JJV, M., & SD, S. (2021). Effects of Sacubitril/Valsartan on Serum Lipids in Heart Failure With Preserved Ejection Fraction.. Journal of the American Heart Association. https://doi.org/10.1161/jaha.121.022069
Source records
- pubmed · retrieved 2026-09-26T22:34:23.646Z